by in
Entry Author Date Location
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
OncoMed Pharmaceuticals Soars in IPO Debut 07/18/13 San Francisco
Stemline Therapeutics Lands $33,000,000 New Round 01/29/13 New York
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model 06/08/11 New York
Stemline Therapeutics Garners $600,000 New Financing 06/30/10 New York
Page 1 of 1